Publicaciones en colaboración con investigadores/as de Hospital de Cruces (7)

2023

  1. Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma

    Analytical Chemistry, Vol. 95, Núm. 4, pp. 2285-2293

2021

  1. High-Resolution Human Kidney Molecular Histology by Imaging Mass Spectrometry of Lipids

    Analytical Chemistry, Vol. 93, Núm. 27, pp. 9364-9372

2020

  1. Influence of Lipid Fragmentation in the Data Analysis of Imaging Mass Spectrometry Experiments

    Journal of the American Society for Mass Spectrometry, Vol. 31, Núm. 3, pp. 517-526

2017

  1. Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B

    Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 4, pp. 636-642

2010

  1. BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin

    Clinical Genetics, Vol. 77, Núm. 1, pp. 60-69

  2. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families

    Cancer Research, Vol. 70, Núm. 19, pp. 7379-7391

2009

  1. The Spanish HIV BioBank: A model of cooperative HIV research

    Retrovirology, Vol. 6